Mr. George Lin

Shanghai, China
George Lin is a healthcare veteran who has over 20 years of investment banking and legal experience working with numerous private and public companies globally. Prior to joining Hua Medicine, he was Asia Pacific Head of Consumer, Retail and Healthcare Investment Banking and Head of Hong Kong and Taiwan Investment Banking for Bank of America Merrill Lynch. As an investment banker and corporate lawyer, Mr. Lin was previously based in LA and SF before moving to Hong Kong in 2007. His experience entails IPOs, debt and equity financings and M&As for leading companies in Asia, the US and Europe. In the last 10 years alone, Mr. Lin has led M&A transactions valued totaling over US$20 billion and raised financings valued totaling over US$40 billion. Since April 2018, Mr. Lin has served as a member of the Biotech Advisory Panel of the Hong Kong Stock Exchange. Mr. Lin also worked at Credit Suisse as an investment banker and at O'Melveny & Myers LLP as a corporate attorney in their LA Office. Mr. Lin received a Bachelor of Sciences degree in Biological Sciences from the University of California at Davis and a JD degree from The University of Chicago Law School.
Speaking In
4:45 PM - 5:00 PM
Wednesday, June 5
Hua Medicine is a China-based drug development company currently focused on developing a global…